Beam Therapeutics Inc. is a pioneering biotechnology firm based in Cambridge, Massachusetts, focusing on creating precision genetic medicines. The company is at the forefront of developing innovative treatments for serious diseases, including sickle cell disease, beta-thalassemia, severe alpha-1 antitrypsin deficiency, and certain types of leukemia and lymphoma. With a commitment to advancing healthcare through genetic editing, Beam Therapeutics collaborates with industry leaders like Pfizer and Verve Therapeutics to target rare genetic diseases and cardiovascular conditions, showcasing its dedication to transforming patient care.
A single analyst note sent Kyverna Therapeutics tumbling despite a clinical milestone that had investors cheering just weeks ago, and the question now is whether the selloff marks a buying opportunity or…
The ARK Innovation ETF (NYSEARCA:ARKK) has barely moved this year, gaining about 2% year to date through late June and sitting at roughly $78 per share. That stasis hides a violent tug…
Invasive species represent a $5.4 trillion global problem, with U.S. economic impact alone exceeding $500 billion annually. That’s according to Ben Lamm, CEO of Colossal Biosciences. On episode 245 of the Moonshots…
Wednesday's top analyst upgrades and downgrades included Apple, Boston Scientific, Caterpillar, Ciena, Costco Wholesale, Generac, Hasbro, Rivian Automotive, Steel Dynamics, Tapestry, Trade Desk and Walmart.
Tuesday's top analyst upgrades and downgrades included Adobe, Enterprise Products Partners, Fubo TV, Nvidia, SunPower, Target, Verizon Communications and Walmart.
Friday's top analyst upgrades and downgrades included CenterPoint Energy, Cloudflare, Dynavax Technologies, HCA Healthcare, Opendoor Technologies, Roku, Salesforce.com, Spotify Technology and Wheaton Precious Metals.
One of the hottest recent IPOs, Coinbase, reports June-quarter earnings Tuesday afternoon. Coinbase and three other stocks are held in Cathie Wood's ARK ETFs.
Tuesday's top analyst upgrades and downgrades included Alphabet, Bank of America, Boeing, Coinbase, Dollar General, Kroger and McDonald's.
Monday's top analyst upgrades and downgrades included Apache, CME, Cree, On Semiconductor, Pioneer Natural Resources, Plug Power, Sony and Wayfair.
Tuesday's top analyst upgrades and downgrades included American Express, BlackBerry, BP, CrowdStrike, Noble Midstream, Waste Management and Zscaler.
Friday's top analyst upgrades and downgrades included AGCO, Caterpillar, Chewy, Clorox, Costco Wholesale, First Solar, Netflix, Snap, Starbucks and Wynn Resorts.
The analysts at its underwriting firms are quite positive on Beam Therapeutics, now that its post-IPO quiet period has come to an end.
Jon C. Ogg Monday's top analyst upgrades, downgrades and initiations included ABB, Apple, Baidu, Casper Sleep, General Electric, Groupon, JPMorgan, Micron Technology, PPD, Verizon Communications and Wayfair.
